Arsenic trioxide (As2O3) as a maintenance therapy for adult T cell leukemia/lymphoma

Arsenic trioxide (As2O3) as a maintenance therapy for adult T cell leukemia/lymphoma

Abstract Background Adult T-cell leukemia-lymphoma (ATL) is an aggressive mature lymphoid proliferation associated with poor prognosis. Standard of care includes chemotherapy and/or the combination of zidovudine and interferon-alpha. However, most patients experience relapse less than 6 months after...

Full description

Bibliographic Details
Main Authors: Ambroise Marçais, Lucy Cook, Aviva Witkover, Vahid Asnafi, Véronique Avettand-Fenoel, Richard Delarue, Morgane Cheminant, David Sibon, Laurent Frenzel, Hugues de Thé, Charles R. M. Bangham, Ali Bazarbachi, Olivier Hermine, Felipe Suarez
Format: Article
Language:English
Published: BMC 2020-03-01
Series:Retrovirology
Subjects:
Arsenic trioxide
ATL
Online Access:http://link.springer.com/article/10.1186/s12977-020-0513-y

Internet

http://link.springer.com/article/10.1186/s12977-020-0513-y

Similar Items